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Table of Contents Summary: 
In this study of 4525 children a one hour longer sleep duration was associated with lower 
levels of adiposity, insulin resistance and fasting glucose.   
 
What’s Known on This Subject 
Shorter sleep duration has been associated with type 2 diabetes (T2D) in adults, and with 
obesity both in adults and children. However, associations between sleep duration and T2D 
risk markers in childhood have been little studied.   
 
What This Study Adds 
This study demonstrates a novel graded association between short sleep duration and elevated 
type 2 diabetes risk markers in a large multi-ethnic population of 9-10 year-old children.  The 
report confirms the association between short sleep duration and body fatness. 
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Abstract 
Background:  Associations between sleep duration and Type 2 diabetes (T2D) risk markers 
in childhood have been little studied.  We examined associations between self-reported sleep 
duration and T2D risk markers in children. 
Methods:  Cross-sectional study of 4525 multi-ethnic UK children aged 9-10 years.  Sleep 
time was calculated from self-reported usual time of going to bed and getting up on a school 
day.  Sleep duration was validated in a sub-set using accelerometers.  Fasting blood samples 
provided levels of serum lipids and insulin, plasma glucose, HbA1c.  Physical measures 
included height, weight, bioimpedance and blood pressures. Multilevel linear regression 
models of anthropometric, T2D and cardiovascular risk markers with sleep duration were 
adjusted for sex, age, month, ethnicity, socioeconomic position, observer (physical measures 
only) and random effect of school.  
Results: On average children slept 10.5 hours/night (95% range 8.0-12.0 hours). There were 
strong inverse graded relationships between sleep duration, adiposity and diabetes risk 
markers. In adjusted models, a one hour greater sleep duration was associated with 0.19kg/m2 
lower body mass index (95%CI 0.09,0.28kg/m2), 0.03 kg/m5 lower fat-mass index (95%CI 
0.00,0.05kg/m5), 2.9% lower HOMA insulin resistance (95%CI 1.2,4.4%), and 0.24% lower 
fasting glucose (95%CI 0.03,0.44%); there was no association with HbA1c or with 
cardiovascular risk.  Associations with insulin and glucose remained after additional 
adjustment for adiposity markers. 
Conclusions: The finding of an inverse association between sleep duration and T2D risk 
markers in childhood is novel.  Intervention studies are needed to establish the causality of 
these associations, which could provide a simple strategy for early T2D prevention. 
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Introduction 
The prevalence of type 2 diabetes (T2D), overweight and obesity have been rising in the UK 
and in many other countries,1,2 not only in adults but also in adolescents and children.3  
Understanding the early determinants of adiposity and T2D risk in young people could be 
particularly important for reducing risks of T2D and obesity across the life course.   
 
There has been particular interest in the importance of sleep for T2D and adiposity risks.  
Sleep duration has complex prospective relations with adiposity and T2D in adults, with both 
short and long sleep durations associated with higher risk.4-6  In contrast, studies in childhood 
have shown graded inverse associations between sleep duration and levels of adiposity, with 
increased sleep duration associated with lower levels of obesity; there has been little evidence 
that longer sleep duration is associated with increased adiposity.5,7  However, little is known 
about the effects of sleep on other T2D risk markers in childhood, particularly glycaemic 
blood markers and insulin resistance.  Such associations could be of public health 
importance; while sleep durations have appeared relatively stable in adulthood,8 recent 
evidence suggests that average sleep duration has declined in children and adolescents over 
time, particularly over the last 15 years where actual sleep duration has declined by 0.73 
minutes per year.9  The ramifications of these reduced sleep durations on future health are yet 
to be established.  However, if shorter sleep duration is related to emerging T2D risk in 
childhood, evidence on optimal sleep duration for protecting against T2D risk could underpin 
efforts to prevent T2D risk at an early stage.10  Moreover, early ethnic differences in T2D 
precursors, particularly where South Asians have a worse metabolic profile compared to 
children of white European ancestry,11 might be partially explained by differences in sleep 
duration.  If so, this may offer a further strategy to reduce ethnic differences in T2D risk in 
early life. 
 
 
 
We therefore examined the association between self-reported sleep duration, T2D and 
cardiovascular risk factors, in a large-scale multi-ethnic population based study of 9 to 10 
year old children.  
 
 
Patients and Methods 
The Child Heart and Health Study in England (CHASE) was a cross-sectional investigation 
of the cardiovascular and type 2 diabetes risk profiles of UK primary school children aged 9-
10 years of white European, South Asian and black African-Caribbean origin.  Ethical 
approval was obtained from the relevant multicentre research ethics committee.  Full details 
of study methods have been published.11  The study was based in 200 state primary schools in 
London, Birmingham and Leicester, half with a high prevalence of  UK South Asian children 
(stratified by Indian, Pakistani and Bangladeshi origin) and half with a high prevalence of UK 
black African-Caribbean children (stratified by black African and black Caribbean origin).  
Informed parental consent and child assent were obtained. 
Measurements of body composition 
A single survey team of three trained Research Nurses made all measurements between 
October 2004 and February 2007; to limit ethnic differences in observer bias, each observer 
measured approximately one-third of children in each ethnic group.  Height and weight were 
measured and body mass index (BMI) calculated as kg/m².  To provide an objective measure 
of adiposity, fat mass was determined from arm-to-leg bioelectrical impedance, measured on 
the right side using the Bodystat 1500 bioelectrical impedance monitor (Bodystat Ltd, Isle of 
Man, UK); fat mass was derived using equations derived specifically for UK children of this 
age group which were sex and ethnic group specific.12  Fat mass was height-standardized (fat 
mass index = fat mass (kg)/height (m)5). Skinfold thicknesses were also measured to provide 
a subcutaneous measure of adiposity, at the biceps, triceps, subcapsular and suprailiac 
locations  Skinfold thickness provide a better predictor of body fatness, compared to weight-
for-height measures.  Seated blood pressure (BP) was measured twice in the right arm after a 
5 minute rest using an Omron HEM-907 (Omron Electronics Ltd., Milton Keynes, UK) with 
 
 
the appropriate cuff size; the mean of the two values was used in analysis after adjustment for 
cuff size.13 
Blood measurements 
A blood sample was obtained after an overnight fast; children were asked not to eat on the 
morning of the examination and those who reported having eaten breakfast were excluded 
from analysis.  Serum for insulin assay was separated and frozen on dry ice immediately after 
collection.  All other samples were shipped to a central laboratory within 48 hours.  Insulin, 
glucose, glycated haemoglobin (HbA1c) and blood lipids were measured as described 
previously.  The homeostasis model assessment (HOMA) model equations were used to 
provide an estimate of insulin resistance.14  Serum urate was assayed using an enzymatic 
method.15 
Questionnaire data 
Children were asked two questions on sleeping habits on a school day; “what time do you 
usually go to bed on schooldays?” and “what time do you usually get up in the morning on 
schooldays?”.  The difference between these two times was used to define sleep duration.  
Ethnic origin of the child was based on self-defined parental ethnicity (coded using a 
classification similar to the 2001 UK Census) or (if not available) parental report of the ethnic 
origin of the child or using information on the report of parental and grand-parental place of 
birth as previously described.11 In the present analyses, ‘white European’ includes children 
whose ethnic origin was defined as ‘white British’, ‘white Irish’ and ‘white European’ (or a 
combination of these) and excludes ‘white Other’.  ‘South Asian’ includes ‘Indian’, 
‘Pakistani’, ‘Bangladeshi’ and ‘Sri Lankan’ (or a combination of these).  Remaining Asian 
children were classified as ‘Asian Other’ and included Asian-mixed ethnicity, Chinese and 
Middle-Eastern ethnic groups.  ‘Black African-Caribbean’ includes ‘Black African’, ‘Black 
Caribbean’, ‘Black British’ and ‘Black Other’ (or combination of these).  Children of other 
 
 
ethnic groups and mixed ethnic origin (except Asian) were allocated to a separate ‘Other’ 
group.  Parental socio-economic position was based on self-reported parental occupation and 
coded using UK National Statistics Socioeconomic Classification (NS-SEC) for the parent 
with the highest NS-SEC grade.16  The three class version was used in all analyses 
(professional and managerial, intermediate, routine and manual) as previously described.17  
Self-reported pubertal status was measured in girls only, using the Tanner development 
score.18 
Physical activity assessment 
In a subset of children, recruited from 79 schools in the latter phase of the study (January 
2006 to February 2007), objective assessment of physical activity was carried out using a 
waist-worn accelerometer (ActiGraph GT1M, ActiGraph, LLC, Pensacola, FL).  Details of 
the physical activity assessment have been published previously.19  In brief, children were 
asked to wear the monitor (worn at the waist above the left hip using an elasticated belt) 
during waking hours for seven whole days.  On return of the instrument a dedicated software 
program was used to determine activity outcomes, including steps by hour of the day, 
allowing activities before and after self-reported bed times to be examined.  It also allowed a 
comparison of monitor non-wear time and reported sleep duration. 
Statistical Analysis 
Statistical analyses were carried out using STATA/SE software (Stata 13 for Windows, 
StataCorp LP, College Station, TX, USA). All diabetes and cardiovascular risk markers and 
body composition variables were examined for normality and log transformed where 
necessary. Multilevel linear regression models adjusted for age in quartiles, sex, month, 
ethnicity, social position and random effect for school were used to calculate adjusted means 
for measures of body composition and diabetes / cardiovascular risk markers by five 
categories of sleep duration (less than 9 hours, 9 to 9.9 hours, 10 to 10.9 hours, 11 to 11.9 
 
 
hours and 12 hours or more). Continuous linear associations with sleep duration in hours 
were determined using the same adjustments; for outcomes that were log transformed 
associations are quantified as the percentage difference per extra hour of sleep. Associations 
with sleep duration were also examined in boys and girls separately and by ethnicity.  Effects 
of adjustment for pubertal status (girls only) were also explored.  Linear associations between 
sleep duration, T2D and cardiovascular risk markers which were statistically significant were 
further adjusted for measures of adiposity including fat mass index and fat free mass index.  
The contribution of sleep duration to previously reported ethnic differences in diabetes and 
cardiovascular risk markers 11,20 was also examined. 
  
 
 
Results 
Of 8641 children invited to participate in CHASE, 5887 (68%) took part.  Among 5681 
singleton children, 4525 (80%) provided a fasting blood sample, had complete data for 
measures of body composition and self-reported data for bedtime and getting up time on a 
school day. On average children were 10.0 years old (SD 0.4 years, reference range 9.2 to 
10.7 years).  Sleep duration was on average 10.5 hours per night on a school day (95% central 
range 8.0 to 12.0 hours – Figure 1).  In a subset of 1766 children who wore an accelerometer 
during waking hours, a mean of 600 steps per hour were recorded during the hours of 8am to 
7pm on a school day but only 54 steps in the hour after reported bedtime, compared with 234 
steps in the hour before bedtime.  One hour before wake up time the number of steps 
recorded was zero compared with 435 steps on average one hour after wake time.  In the 
subset that wore an accelerometer, daily non-wear time was 10.2 hours, and reported sleep 
duration 10.3 hours (equivalent to a mean difference of 7 minutes, 95% CI 4 to 10 minutes). 
 
Table 1 shows demographic characteristics of the children in relation to sleep duration on a 
school day.  Children who had longer sleep duration were on average slightly younger and 
were more likely to be girls (Table 1). Sleep duration differed marginally by ethnicity; white 
European children had the longest mean sleep duration and Black African Caribbean children 
the shortest. There was no clear evidence of any trend in sleep duration by parental social 
position. 
 
There were strong inverse linear relationships between sleep duration and all measures of 
body size and fatness (Figure 2, Table 2 and Supplementary Figure S1). Children who slept 
longer were on average shorter, had lower body weight, fat free mass and lower levels of fat 
mass index and skinfold thickness; effect sizes for adiposity measures, including BMI, sum 
 
 
of skinfolds, and leptin, were statistically significant and between 1-3% per extra hour of 
sleep. Sleep duration was also inversely related to insulin, insulin resistance and glucose. Per 
extra hour of sleep insulin levels were lower by nearly 3% (95%CI from 1.2% to 4.5% 
reduction) and a similar association was seen for insulin resistance (Table 2). The size of the 
association with glucose was smaller and there was no clear evidence of an association with 
HbA1c (Table 2). There was no evidence of associations with lipids or blood pressure. Very 
similar strengths of associations were found in analyses stratified by ethnicity and gender. 
(Supplementary Table S1).  There was no consistent evidence of effect modification by 
gender (likelihood ratio test (LRT) for interaction with gender p-value >0.1 for all measures 
of body size and cardio-metabolic risk markers) or ethnicity (LRT p value for interaction 
>0.2 in all instances). 
 
In addition to factors adjusted for in Table 2, Table 3 shows associations with insulin and 
insulin resistance were slightly attenuated, with further adjustment for height (Table 3; model 
1). Additional adjustment for fat mass index (model 2) or fat free mass index (model 3) or 
both (model 4) attenuated the associations further for insulin and insulin resistance, and were 
no longer statistically significant after adjustment for fat free mass index. In the fully adjusted 
(model 4) coefficients were approximately halved when compared with coefficients in Table 
2 that did not adjust for height or adiposity. Associations between sleep duration and glucose 
were little affected by adjustment for height or body fatness.  Adjustment for pubertal status 
(recorded in girls only) also made no difference to the findings, as did exclusion of girls who 
had entered puberty.  Physical activity was recorded objectively over a week in a subset of 
children (n=1492) using Actigraph monitors.  Adjustment for the average level of physical 
activity on a school day did not alter the results, but there was a loss in power due to the 
analyses being based on reduced numbers. 
 
 
 
We examined ethnic differences in T2D precursors before and after adjustment for sleep 
duration.  Compared with white Europeans, black African Caribbean children had 8.5% 
higher levels of insulin (95% CI 3.2% to 14.0%) after adjustment for age quartiles, sex, 
height, month, social position; this difference reduced to 7.6% higher (2.3% to 13.3%) with 
additional adjustment for sleep duration.  In South Asian children the difference in insulin 
levels compared to White European was 30.3% (23.9% to 36.9%) before adjustment for sleep 
duration and 29.5% (23.3% to 36.3%) after adjustment for sleep duration.  
 
 
Discussion 
Main findings 
The present study is novel in showing inverse associations between reported sleep duration 
and T2D risk factors in early life, which are independent of adiposity, and observed in 
different ethnicities. It also shows strong inverse associations between reported sleep duration 
and adiposity, including detailed measures of body fatness, confirming findings from earlier 
studies. Given the rising prevalence of diabetes worldwide, and especially in low to middle 
income countries, we believe our findings will help motivate further simple pragmatic trials 
in this area. 
 
Relation to earlier studies 
Both short and long sleep duration have been linked to adiposity and T2D in adulthood.4-6  
Previous cross sectional observations in childhood have shown inverse association between 
sleep duration, levels of BMI and obesity, with BMI being 0.75 kg/m² lower for every 
additional hour of sleep,21 and pooled estimates suggest short durations of sleep are 
associated with a near doubling of obesity prevalence compared to long durations.5,22  These 
associations have also been confirmed in analysis of prospective studies in childhood, which 
have shown slightly smaller associations with 0.5 kg/m² lower BMI per hour of sleep.23  
These observations concur with adult observations, where pooled findings suggest inverse 
associations between sleep duration, BMI and obesity.5  The present study confirms the 
inverse association with BMI and extends these observations by demonstrating strong graded 
inverse associations with more detailed measures of adiposity, including sum of skin folds 
and bioelectrical impedance derived measures of fat mass.  Inverse associations between 
height and sleep duration may well be explained by maturation, with more mature children 
tending to have later weekday bedtimes.  The inverse association with leptin is of particular 
 
 
interest, as this may allude to a biological mechanism of effect, by which increased sleep may 
alter appetite, by down regulation of leptin production,24 although we accept circulating leptin 
levels generally reflect fat mass in stable weight individuals. This agrees with earlier work 
suggesting that short sleep durations in childhood are associated with higher intake of energy 
dense and sugary foods.25 
 
The present study is also novel in demonstrating inverse associations between reported sleep 
duration and T2D risk markers, including insulin, insulin resistance and blood glucose 
(although associations with HbA1c were marginal).  These associations appear to be partially 
independent of the detailed adiposity measures.  One previous small study (sample size of 
245 participants) has shown an inverse association between sleep duration and HOMA 
measures of insulin resistance in adolescence.26  However, we are not aware of any other 
population based studies that have reported similar associations earlier in childhood, except 
amongst high-risk obese children.27  Sleep duration did not appear to explain early ethnic 
differences in T2D risk previously reported, particularly the higher levels of insulin resistance 
and glycaemia among South Asian children.11 
 
The present study also provided the opportunity to examine sleep durations and 
cardiovascular risk factors, including blood lipids and blood pressure, where there was no 
consistent evidence of an association.  These null findings are in agreement with a limited 
number of earlier observations in childhood,28,29 suggesting that sleep duration does not alter 
other cardiovascular risk in early life, other than by increased obesity and metabolic risks 
which, if sustained or accentuated, take time to accelerate cardiovascular risks. 
 
Strengths and limitations 
 
 
The present study has a number of strengths and limitations which require further 
consideration.  The study was large, and included multi-ethnic child population.  Although 
ethnic differences in sleep duration were observed, where white European children slept the 
longest and black Africans the shortest, associations with adiposity measures and T2D risk 
were consistent across ethnic groups.  Moreover, associations were not materially altered by 
adjustment for socioeconomic position, pubertal status (in girls only), and remained after 
adjustment for other potential confounders (i.e., sleep-T2D associations remained after 
adjustment for measures of adiposity).  The study was cross sectional, which should not be 
judged as a disadvantage given the plausible short-term effects of sleep duration on 
cardiometabolic risk.  The possibility of reverse causality, where metabolic dysregulation 
alter sleep patterns, seems unlikely given the child population.30  Reassuringly findings were 
consistent with observations from longitudinal studies, as outlined above.  One potential 
weakness was that sleep duration was derived from weekday self-reported bed-times, not 
weekend reported bed-times, which may underestimate total weekly sleep duration.31  
However, reported mean and distribution of sleep time was in keeping with other studies of 
similarly aged children (i.e., mean 10.3 SD 1.1 hours versus 10.5, SD 0.7 hours in a large 
cohort of children aged 9 years).32  Accelerometer assessment in a subset 19 provided a further 
validation of sleep time, showing similar monitor non-wear time and reported sleep duration, 
and that on average children recorded very few steps 1 hour before compared to 1 hour after 
reported wake time, and far fewer steps 1 hour after compared to 1 before reported bed time.  
However, a reduction or absence of steps may not fully reflect sleep, only rest, as other 
sedentary activities could be taking place.  Moreover, waking time accelerometer, as opposed 
to sleep time accelerometry, does not allow sleep quality to be assessed, which could 
plausibly exert metabolic effects.33 
 
 
 
Biological mechanisms by which sleep may alter T2D risk have been proposed, including the 
dysregulation of neuroendocrine control of appetite.24,34  This lends weight to a potentially 
causal association.  If the association is indeed causal, it would be important to establish 
evidence based sleep time recommendations, which would be particularly relevant, given 
trends towards decreasing sleep time in contemporary children.9  However, robust 
experimental evidence (i.e. trials) on the association between sleep duration and T2D risk is 
needed before causality can be inferred.  Unfortunately, evidence from a small number of 
experimental studies both in childhood and adulthood examining the effects of changing 
sleep duration on adiposity has so far been inconclusive, largely because the effects of 
interventions on sleep duration have been modest.35,36  Hence, interventions which are more 
effective in altering sleep duration are needed.  Establishing causality is a priority, as 
increasing sleep duration could offer a simple, cost effective approach to reducing adiposity 
and T2D risk from early life. 
 
Conclusions 
In the present study, increasing the mean weekday sleep duration (10.5 hrs) by half an hour, 
could be associated with 0.1 kg/m² lower BMI, and a 0.5% reduction in insulin resistance.  
These differences should be considered in relation to the largest observed ethnic difference in 
BMI and insulin resistance within this study population, where children of South Asian origin 
had 30% higher insulin resistance,11 and 0.4 kg/m² lower BMI compared to children of white 
European ancestry.37  If experimental evidence were to corroborate the associations observed 
between sleep duration and Type 2 diabetes precursors, allowing a causal association to be 
inferred, these effects could plausibly persist into later life.  Levels of insulin resistance in 
childhood have been shown to impact on T2D risk over a 10 year period and may magnify 
with increasing age.38 Hence, reducing levels, even by modest amounts in childhood, may 
 
 
have longer-term implications for reduced T2D in later life.39  Furthermore, greater weight 
gain trajectories in childhood associate with greater risks for adolescent non-alcoholic fatty 
liver disease, a well-accepted precursor to diabetes risks.40   
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Table 1:  Demographic characteristics for 4525 children by duration of sleep with adjusted 
average sleep duration. 
 
Table 2:  Adjusted mean values of type 2 diabetes and cardiovascular risk markers and 
difference in risk markers per hour increase in sleep. 
 
Table 3: Adjusted difference in type 2 diabetes risk markers per hour increase in sleep. 
 
Table S1: Adjusted mean values of body size, body fatness type 2 diabetes and 
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Legends for figures 
Figure 1: Distribution of hours of sleep on school days. 
 
Figure 2: Adjusted means for type 2 diabetes risk markers and body fatness indices by sleep 
duration. Means are adjusted for sex, age quartiles, month, ethnicity, social position, observer 
(physical measures only) and random effect for school. 
 
Figure S1: Adjusted means for body size and adiposity markers by sleep duration (adjusted 
for sex, age quartiles, month, ethnicity, social position, observer (physical measures only) and 
random effect for school). 
 
 
Table 1: 
 
 
Hours of self-reported sleep on a school night $ 
  
 
Less than 9 
hours 9-9.9hrs 10-10.9hrs 11-11.9hrs 12hrs or more 
Adjusted mean 
sleep P value† 
N =  279 (6.2%) 
841 
(18.6%) 
2014 
(44.5%) 
1166 
(25.8%) 225 (5%) 
hours (95%CI) 
 Average age years (SD) 10.0 (0.4) 10.0 (0.4) 10.0 (0.4) 9.0 (0.4) 9.8 (0.4) 10.3 (10.2, 10.3) 0.05 
Males 180(8.2) 431(19.7) 963(44.1) 501(22.9) 110(5.0) 10.2 (10.1, 10.2) 
 Females 99(4.2) 410(17.5) 1051(44.9) 665(28.4) 115(4.9) 10.4 (10.3, 10.4) <0.0001 
Ethnic group 
       White European  43(3.9) 179(16.4) 493(45.3) 316(29.0) 58(5.3) 10.4 (10.3, 10.5) <0.0001 
Black African-
Caribbean 87(7.6) 245(21.4) 508(44.4) 252(22.0) 51(4.5) 10.1 (10.1, 10.2) 
 South-Asian 89(7.2) 217(17.5) 551(44.4) 335(27.0) 50(4.0) 10.2 (10.2, 10.3) 
 Asian Other 17(6.1) 56(20.1) 121(43.5) 71(25.5) 13(4.7) 10.2 (10.1, 10.3) 
 Other 43(5.6) 144(18.6) 341(44.1) 192(24.8) 53(6.9) 10.3 (10.2, 10.4) 
 Parental social economic position 
     
 
Managerial/Professional 55(4.3) 220(17.4) 629(49.6) 316(24.9) 47(3.7) 10.3 (10.2, 10.4) 0.04 
Intermediate 75(6.5) 239(20.6) 511(44.1) 290(25.0) 45(3.9) 10.2 (10.1, 10.3) 
 
Routine/Manual 96(6.9) 254(18.3) 586(42.3) 361(26.1) 88(6.4) 10.3 (10.2, 10.3) 
 Economically Inactive 33(7.2) 77(16.9) 171(37.5) 143(31.4) 32(7.0) 10.3 (10.2, 10.4) 
 
Unclassified/missing 20(7.8) 51(19.8) 117(45.5) 56(21.8) 13(5.1) 10.2 (10.1, 10.3) 
 
 
$ values are mean and SD for age; for all categorical variables values are N (row %) 
† p-value from likelihood ratio test for heterogeneity from the same multilevel model 
  
 
 
Table 2: 
 
  
Adjusted means (95% confidence 
intervals) 
 
 
 
 
 
Hours of self-reported sleep on a school night 
 
 
 
 
Less than 9 
hours 9-9.9hrs 10-10.9hrs 11-11.9hrs 
12hrs or 
more 
Difference 
per hour 
 
Body size 279 841 2014 1166 225 
of sleep 
(95%CI) ** p-value† 
Height (cm) 
140.1 
(139.3,140.9) 
141.0 
(140.6,141.5) 
140.2 
(139.9,140.5) 
140.0 
(139.6,140.4) 
139.0 
(138.2,139.9) 
-0.26 
(-0.44,-0.08) 
0.005 
Weight (Kg) 
37.8 
(36.7,38.9) 
38.2 
(37.6,38.8) 
37.2 
(36.8,37.6) 
36.5 
(36.0,37.0) 
35.4 
(34.2,36.6) 
-0.51 
(-0.76,-0.26) 
<0.0001 
Body mass index 
(kg/m2) 
19.1 
(18.7,19.5) 
19.0 
(18.8,19.3) 
18.7 
(18.6,18.9) 
18.4 
(18.2,18.6) 
18.2 
(17.7,18.6) 
-0.19 
(-0.28,-0.09) 
<0.0001 
Sum skin folds (mm)* 
42.0 
(39.6,44.5) 
42.8 
(41.3,44.2) 
41.2 
(40.3,42.1) 
39.9 
(38.8,41.1) 
38.8 
(36.4,41.3) 
-1.79 
(-3.08,-0.49) 
0.007 
Fat mass (Kg) 
12.6 
(12.0,13.3) 
12.7 
(12.3,13.1) 
12.3 
(12.0,12.5) 
11.8 
(11.5,12.2) 
11.2 
(10.5,12.0) 
-0.27 
(-0.42,-0.11) 
0.001 
Fat free mass (Kg) 
25.2 
(24.7,25.7) 
25.5 
(25.2,25.8) 
25.0 
(24.8,25.2) 
24.7 
(24.5,24.9) 
24.2 
(23.7,24.8) 
-0.24 
(-0.35, -0.13) 
<0.0001 
Fat mass index 
(Kg/m5) 
2.29 
(2.19,2.39) 
2.21 
(2.15,2.27) 
2.21 
(2.17,2.26) 
2.15 
(2.10,2.20) 
2.13 
(2.02,2.24) 
-0.03 
(-0.05,0.00) 
0.03 
Fat-free mass index 
(Kg/m3) 
9.11 
(9.01,9.22) 
9.06 
(8.99,9.12) 
9.01 
(8.96,9.06) 
8.95 
(8.89,9.01) 
8.97 
(8.86,9.09) 
-0.04 
(-0.06,-0.01) 
0.002 
Cardiometabolic risk markers 
      
Insulin (mU/L)*‡ 
7.68 
(7.12,8.29) 
7.57 
(7.22,7.93) 
7.42 
(7.17,7.69) 
7.12 
(6.83,7.43) 
6.42 
(5.90,6.98) 
-2.88 
(-4.50, -1.23) 
0.001 
Insulin resistance*‡ 
0.97 
(0.90,1.04) 
0.95 
(0.91,1.00) 
0.93 
(0.90,0.97) 
0.90 
(0.86,0.94) 
0.81 
(0.75,0.88) 
-2.81 
(-4.41, -1.17) 
0.001 
Glucose (mmol/L)* 
4.55 
(4.50,4.59) 
4.53 
(4.50,4.56) 
4.52 
(4.50,4.54) 
4.49 
(4.47,4.52) 
4.53 
(4.48,4.57) 
-0.24 
(-0.44, -0.03) 
0.03 
 
 
HbA1c (%) 
5.27 
(5.23,5.31) 
5.26 
(5.24,5.29) 
5.25 
(5.23,5.26) 
5.24 
(5.22,5.26) 
5.24 
(5.20,5.28) 
-0.01 
(-0.02, 0.00) 
0.11 
HbA1c (mmol/mol) 
34 
(34,35) 
34 
(34,34) 
34 
(34,34) 
34 
(34,34) 
34 
(34,34)  
0.11 
Leptin (ng/mL)*‡ 
9.2 
(8.2,10.3) 
9.7 
(9.1,10.4) 
9.5 
9.1,9.9) 
8.6 
(8.1,9.1) 
8.0 
(7.1,9.0) 
-3.03 
(-5.42, -0.59) 
0.02 
Total cholesterol 
(mmol/L) 
4.6 
(4.5,4.7) 
4.6 
(4.5,4.6) 
4.6 
(4.5,4.6) 
4.6 
(4.5,4.6) 
4.5 
(4.4,4.6) 
-0.01 
(-0.03, 0.01) 
0.32 
LDL cholesterol 
(mmol/L) 
2.7 
(2.6,2.8) 
2.7 
(2.6,2.7) 
2.7 
(2.6,2.7) 
2.7 
(2.7,2.7) 
2.7 
(2.6,2.8) 
-0.01 
(-0.02, 0.01) 
0.57 
HDL cholesterol 
(mmol/L) 
1.5 
(1.5,1.5) 
1.5 
(1.5,1.5) 
1.5 
(1.5,1.5) 
1.5 
(1.5,1.5) 
1.5 
(1.5,1.5) 
0.00 
(-0.01, 0.01) 
0.70 
Triglyceride 
(mmol/L)* 
0.8 
(0.8,0.8) 
0.8 
(0.8,0.8) 
0.8 
(0.8,0.8) 
0.8 
(0.8,0.8) 
0.8 
(0.7,0.8) 
-0.35 
(-1.37, 0.67) 
0.50 
Urate (mmol/L)* 
0.2 
(0.2,0.2) 
0.2 
(0.2,0.2) 
0.2 
(0.2,0.2) 
0.2 
(0.2,0.2) 
0.2 
(0.2,0.2) 
0.20 
(-0.48, 0.89) 
0.56 
Systolic blood 
pressure (mmHg) 
104.1 
(102.9,105.4) 
105.1 
(104.3,105.8) 
104.9 
(104.4,105.4) 
104.5 
(103.8,105.1) 
104.3 
(102.9,105.7) 
0.03 
(-0.25, 0.31) 
0.84 
Diastolic blood 
pressure (mmHg) 
62.9 
(61.8,64.1) 
63.5 
(62.8,64.2) 
63.0 
(62.4,63.5) 
62.8 
(62.2,63.4) 
62.4 
(61.2,63.6) 
0.00 
(-0.25, 0.25) 
0.97 
Adjusted means of outcome variables by sleep category from multilevel model adjusted for sex, age quartiles, month, ethnicity, social position, 
observer (physical measures only) and random effect for school 
* geometric means for log transformed variables 
‡ insulin and insulin resistance missing data for 76 children, leptin missing data for 97 children 
**regression coefficients from multilevel model for continuous association with hours of sleep adjusted for sex, age quartiles, month, ethnicity, 
social position, observer (physical measures only) and random effect for school. For log transformed outcomes these represent % differences  
†p-values for regression coefficient from the multilevel model assuming a linear continuous association with sleep duration  
 
 
Table 3: 
 
 
% difference in metabolic risk marker per 1 hr increase in sleep (95% confidence interval); P-value 
Model Insulin Insulin resistance Glucose HbA1c 
1 -2.22 (-3.77, -0.65) 0.006 -2.16 (-3.70, -0.60) 0.007 -0.21 (-0.42, -0.01) 0.04 -0.01 (-0.01, 0.00) 0.14 
2 -1.49 (-2.89, -0.07) 0.04 -2.16 (-3.70, -0.60) 0.007 -0.22 (-0.42, -0.01) 0.04 0.00 (0.00, 0.00) 0.31 
3 -1.09 (-2.52, 0.37) 0.14 -1.04 (-2.47, 0.41) 0.16 -0.19 (-0.39, 0.02) 0.08 -0.01 (-0.01, 0.00) 0.20 
4 -1.15 (-2.54, 0.26) 0.11 -1.04 (-2.47, 0.41) 0.16 -0.20 (-0.41, 0.00) 0.05 -0.01 (-0.01, 0.00) 0.14 
Model 1 includes adjustment for sex, age quartiles, month, ethnicity, social position, anthropometric observer, height and random effect for 
school 
Model 2 as in Model 1 plus fat mass index  
Model 3 as in Model 1 plus fat free mass index 
Model 4 as in Model 1 plus fat mass index and fat free mass index 
Insulin and insulin resistance missing data for 76 children 
 
 
 
Table S1: 
Table S1 Adjusted mean values of body size, body fatness type 2 diabetes and cardiovascular risk markers and 
difference in marker per hour increase in sleep in boys and girls separately (analysis stratified by gender) 
BOYS 
 
Body size 
Hours of sleep on a school night 
Difference per hour of sleep 
(95%CI) ** 
p-
value† Less than 9 
hours 
9 to 9.9 hours 
10 to 10.9 
hours 
11 to 11.9 
hours 
12 hours or 
more 
Height (cm) 
139.5 
(138.6,140.5) 
140.6 
(140.0,141.2) 
139.9 
(139.4,140.3) 
139.9 
(139.4,140.5) 
138.8 
(137.6,140.0) 
-0.17 (-0.40, 0.06) 0.151 
Weight (Kg) 
37.1 
(35.8,38.3) 
37.6 
(36.8,38.5) 
36.5 
(36.0,37.1) 
36.3 
(35.5,37.0) 
34.6 
(33.0,36.3) 
-0.46 (-0.78, -0.15) 0.004 
Ponderal index (kg/m3)* 
13.3 
(13.0,13.6) 
13.2 
(13.0,13.4) 
13.0 
(12.9,13.2) 
12.9 
(12.7,13.1) 
12.7 
(12.3,13.1) 
-0.93 (-1.50, -0.37) 0.001 
Sum skin folds (mm)* 
37.1 
(34.4,40.0) 
38.9 
(37.0,40.8) 
36.5 
(35.3,37.7) 
36.0 
(34.4,37.6) 
33.9 
(30.8,37.4) 
-2.08 (-3.85, -0.28) 0.024 
Fat mass (Kg)* 10.5 (9.8,11.3) 
10.5 
(10.1,11.0) 
10.1 (9.8,10.4) 10.1 (9.7,10.5) 9.5 (8.7,10.3) -2.07 (-3.69, -0.42) 0.014 
Fat free mass (Kg) 
25.4 
(24.8,25.9) 
25.8 
(25.4,26.1) 
25.2 
(25.0,25.5) 
25.0 
(24.7,25.4) 
24.4 
(23.7,25.1) 
-0.21 (-0.35, -0.08) 0.002 
Fat mass index (Kg/m5) 
2.15 
(2.03,2.27) 
2.10 
(2.02,2.18) 
2.06 
(2.00,2.11) 
2.04 
(1.97,2.11) 
1.97 
(1.81,2.12) 
-0.03 (-0.06, 0.00) 0.027 
Fat-free mass index 
(Kg/m3) 
9.31 
(9.18,9.43) 
9.22 
(9.14,9.30) 
9.18 
(9.13,9.24) 
9.10 
(9.02,9.18) 
9.08 
(8.92,9.23) 
-0.05 (-0.08, -0.02) 0.001 
Cardiometabolic markers 
Insulin (mU/L)*‡ 
6.87 
(6.25,7.54) 
6.66 
(6.26,7.09) 
6.52 
(6.22,6.83) 
6.45 
(6.08,6.85) 
5.74 
(5.10,6.46) 
-2.24 (-4.36, -0.07) 0.043 
Insulin resistance*‡ 
0.86 
(0.79,0.95) 
0.84 
(0.79,0.89) 
0.82 
(0.79,0.86) 
0.82 
(0.77,0.87) 
0.73 
(0.65,0.82) 
-2.04 (-4.16, 0.12) 0.065 
Glucose (mmol/L)* 
4.59 
(4.54,4.65) 
4.57 
(4.53,4.60) 
4.55 
(4.53,4.58) 
4.54 
(4.51,4.57) 
4.57 
(4.51,4.64) 
-0.29 (-0.57, -0.02) 0.037 
HbA1c (%) 
5.26 
(5.21,5.31) 
5.26 
(5.23,5.29) 
5.25 
(5.23,5.27) 
5.24 
(5.21,5.27) 
5.24 
(5.18,5.30) 
-0.01 (-0.02, 0.00) 0.235 
HbA1c (mmol/mol) 34 (33,36) 34 (33,34) 34 (33,34) 34 (33,34) 34 (33,34)  0.235 
Leptin (ng/mL)*‡ 6.8 (5.9,7.9) 7.7 (7.1,8.5) 7.3 (6.9,7.8) 6.9 (6.4,7.5) 6.3 (5.2,7.5) -2.49 (-5.75, 0.89) 0.148 
Total cholesterol 
(mmol/L) 
4.6 (4.5,4.8) 4.6 (4.5,4.7) 4.6 (4.5,4.6) 4.6 (4.6,4.7) 4.5 (4.4,4.7) -0.02 (-0.05, 0.01) 0.170 
LDL cholesterol 
(mmol/L) 
2.7 (2.6,2.8) 2.7 (2.6,2.8) 2.7 (2.6,2.7) 2.7 (2.6,2.7) 2.7 (2.6,2.8) -0.02 (-0.04, 0.01) 0.166 
HDL cholesterol 
(mmol/L) 
1.6 (1.5,1.6) 1.5 (1.5,1.6) 1.6 (1.5,1.6) 1.6 (1.6,1.6) 1.5 (1.5,1.6) 0.00 (-0.01, 0.01) 0.686 
Triglyceride (mmol/L)* 0.7 (0.7,0.8) 0.8 (0.7,0.8) 0.8 (0.7,0.8) 0.8 (0.7,0.8) 0.7 (0.7,0.8) -0.56 (-1.92, 0.82) 0.425 
Urate (mmol/L)* 0.2 (0.2,0.2) 0.2 (0.2,0.2) 0.2 (0.2,0.2) 0.2 (0.2,0.2) 0.2 (0.2,0.2) 0.08 (-0.80, 0.96) 0.862 
Systolic blood pressure 
(mmHg) 
104.8 
(103.3,106.4) 
105.7 
(104.7,106.7) 
105.5 
(104.8,106.2) 
104.5 
(103.6,105.5) 
104.6 
(102.7,106.5) 
-0.13 (-0.50, 0.23) 0.477 
Diastolic blood pressure 
(mmHg) 
62.9 
(61.5,64.3) 
63.5 
(62.6,64.5) 
62.9 
(62.2,63.6) 
62.1 
(61.2,63.0) 
62.6 
(60.8,64.3) 
-0.06 (-0.39, 0.27) 0.735 
 
 
 
 
 
GIRLS 
 
Body size 
Hours of sleep on a school night 
Difference per hour of sleep 
(95%CI) ** 
p-
value† Less than 9 
hours 
9 to 9.9 hours 
10 to 10.9 
hours 
11 to 11.9 
hours 
12 hours or 
more 
Height (cm) 
140.9 
(139.5,142.2) 
141.4 
(140.7,142.1) 
140.6 
(140.1,141.0) 
140.1 
(139.5,140.6) 
139.2 
(137.9,140.4) 
-0.42 (-0.71, -0.13) 0.004 
Weight (Kg) 
38.8 
(36.9,40.6) 
38.7 
(37.8,39.7) 
37.8 
(37.2,38.4) 
36.8 
(36.0,37.5) 
36.1 
(34.4,37.8) 
-0.60 (-0.99, -0.20) 0.003 
Ponderal index (kg/m3)* 
13.5 
(13.1,14.0) 
13.3 
(13.1,13.5) 
13.3 
(13.1,13.4) 
13.0 
(12.9,13.2) 
13.1 
(12.7,13.5) 
-0.57 (-1.28, 0.15) 0.122 
Sum skin folds (mm)* 
47.7 
(43.5,52.2) 
46.6 
(44.6,48.8) 
46.0 
(44.7,47.3) 
44.0 
(42.4,45.6) 
44.0 
(40.4,47.8) 
-1.49 (-3.38, 0.43) 0.128 
Fat mass (Kg)* 
12.6 
(11.6,13.7) 
12.0 
(11.5,12.6) 
12.0 
(11.7,12.4) 
11.3 
(10.9,11.7) 
11.1 
(10.2,12.0) 
-2.10 (-3.87, -0.30) 0.023 
Fat free mass (Kg) 
25.11 
(24.28,25.93) 
25.28 
(24.87,25.69) 
24.68 
(24.42,24.95) 
24.33 
(24.00,24.66) 
24.00 
(23.23,24.76) 
-0.29 (-0.46, -0.11) 0.001 
Fat mass index (Kg/m5) 
2.43 
(2.26,2.60) 
2.32 
(2.24,2.41) 
2.36 
(2.30,2.41) 
2.26 
(2.19,2.33) 
2.30 
(2.14,2.46) 
-0.02 (-0.05, 0.02) 0.406 
Fat-free mass index 
(Kg/m3) 
8.90 
(8.72,9.07) 
8.89 
(8.80,8.98) 
8.83 
(8.76,8.89) 
8.80 
(8.73,8.88) 
8.86 
(8.69,9.02) 
-0.02 (-0.06, 0.02) 0.302 
Cardiometabolic markers 
Insulin (mU/L)*‡ 
8.59 
(7.60,9.72) 
8.46 
(7.94,9.02) 
8.33 
(7.99,8.69) 
7.78 
(7.39,8.19) 
7.06 
(6.29,7.93) 
-4.09 (-6.58, -1.54) 0.002 
Insulin resistance*‡ 
1.08 
(0.96,1.22) 
1.07 
(1.00,1.14) 
1.04 
(1.00,1.09) 
0.98 
(0.93,1.03) 
0.89 
(0.79,1.00) 
-4.20 (-6.65, -1.68) 0.001 
Glucose (mmol/L)* 
4.50 
(4.43,4.57) 
4.49 
(4.46,4.53) 
4.48 
(4.45,4.50) 
4.45 
(4.42,4.48) 
4.48 
(4.42,4.54) 
-0.22 (-0.53, 0.10) 0.183 
HbA1c (%) 5.3 (5.2,5.4) 5.3 (5.2,5.3) 5.2 (5.2,5.3) 5.2 (5.2,5.3) 5.3 (5.2,5.3) -0.01 (-0.02, 0.01) 0.261 
HbA1c (mmol/mol) 34 (33,36) 34 (33,34) 34 (33,34) 34 (33,34) 34 (33,34)  0.261 
Leptin (ng/mL)*‡ 
12.6 
(10.6,14.9) 
11.9 
(10.9,13.0) 
12.0 
(11.3,12.8) 
10.6 (9.8,11.4) 10.0 (8.5,11.8) -3.78 (-7.28, -0.15) 0.041 
Total cholesterol 
(mmol/L) 
4.5 (4.3,4.6) 4.5 (4.5,4.6) 4.5 (4.5,4.6) 4.5 (4.5,4.6) 4.5 (4.4,4.7) 0.00 (-0.03, 0.03) 0.936 
LDL cholesterol 
(mmol/L) 
2.6 (2.5,2.8) 2.7 (2.6,2.7) 2.7 (2.6,2.7) 2.7 (2.6,2.7) 2.7 (2.6,2.8) 0.01 (-0.02, 0.04) 0.532 
HDL cholesterol 
(mmol/L) 
1.5 (1.4,1.5) 1.5 (1.5,1.5) 1.5 (1.5,1.5) 1.5 (1.4,1.5) 1.5 (1.4,1.5) -0.01 (-0.02, 0.01) 0.348 
Triglyceride (mmol/L)* 0.9 (0.8,0.9) 0.8 (0.8,0.9) 0.9 (0.8,0.9) 0.8 (0.8,0.9) 0.8 (0.8,0.9) -0.37 (-1.90, 1.20) 0.645 
Urate (mmol/L)* 0.2 (0.2,0.2) 0.2 (0.2,0.2) 0.2 (0.2,0.2) 0.2 (0.2,0.2) 0.2 (0.2,0.2) 0.42 (-0.66, 1.50) 0.449 
Systolic blood pressure 
(mmHg) 
103.0 
(101.0,105.1) 
104.4 
(103.4,105.4) 
104.3 
(103.6,105.0) 
104.3 
(103.5,105.1) 
104.1 
(102.2,106.0) 
0.29 (-0.15, 0.73) 0.194 
Diastolic blood pressure 
(mmHg) 
62.7 
(60.9,64.5) 
63.4 
(62.4,64.3) 
63.0 
(62.4,63.6) 
63.3 
(62.5,64.0) 
62.4 
(60.7,64.1) 
0.10 (-0.29, 0.48) 0.628 
Adjusted means of outcome variables by sleep category from multilevel model adjusted for sex, age quartiles, month, ethnicity, social position, observer (physical 
measures only) and random effect for school 
* geometric means for log transformed variables 
‡ insulin and insulin resistance missing data for 76 children, leptin missing data for 97 children 
**regression coefficients from multilevel model for continuous association with hours of sleep adjusted for sex, age quartiles, month, ethnicity, social position, 
observer (physical measures only) and random effect for school. For log transformed outcomes these represent % differences  
†p-values for regression coefficient from the multilevel model assuming a linear continuous association with sleep duration 
 
 
 
Figure 1: Distribution of hours of sleep on school days. 
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Figure 2: Adjusted means for type 2 diabetes risk markers and body fatness indices by sleep duration. Means are 
adjusted for sex, age quartiles, month, ethnicity, social position, observer (physical measures only) and random effect 
for school. 
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